145 related articles for article (PubMed ID: 28536341)
1. [A Case of Effective Chemoradiotherapy Using mFOLFOX6 for Locally Advanced Rectal Cancer].
Kuga Y; Kitamura S; Mouri T; Miwata T; Hirata Y; Ishizaki Y; Hashimoto Y
Gan To Kagaku Ryoho; 2017 May; 44(5):425-428. PubMed ID: 28536341
[TBL] [Abstract][Full Text] [Related]
2. [A case of effective chemotherapy using S-1 and CPT-11 following chemoradiotherapy with UFT and Leucovorin for unresectable advanced sigmoid colon cancer].
Kuga Y; Tanaka T; Arita M; Okanobu H; Miwata T; Yoshimi S; Murakami E; Numata Y; Moriya T; Ohya T; Nishida T
Gan To Kagaku Ryoho; 2010 Mar; 37(3):531-4. PubMed ID: 20332698
[TBL] [Abstract][Full Text] [Related]
3. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiation therapy using concurrent S-1 and irinotecan in rectal cancer: impact on long-term clinical outcomes and prognostic factors.
Nakamura T; Yamashita K; Sato T; Ema A; Naito M; Watanabe M
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):547-55. PubMed ID: 24929164
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemoradiotherapy for locally advanced rectal cancer].
Kuriu Y; Kokuba Y; Murayama Y; Komatsu S; Shiozaki A; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1951-3. PubMed ID: 23267940
[TBL] [Abstract][Full Text] [Related]
6. [A Case of an Unresectable Locally Advanced Rectal Cancer with Surrounding Organ Invasion Successfully Resected after Chemotherapy with mFOLFOX6 plus Cetuximab].
Takagi H; Ariake K; Takemura S; Doi T
Gan To Kagaku Ryoho; 2016 Mar; 43(3):377-9. PubMed ID: 27067860
[TBL] [Abstract][Full Text] [Related]
7. [A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].
Hirose H; Ikeda M; Miyoshi N; Kim HM; Okano M; Uemura M; Yamashita S; Takemasa I; Mizushima T; Yamamoto H; Ishii H; Sekimoto M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2545-7. PubMed ID: 21224634
[TBL] [Abstract][Full Text] [Related]
8. Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Saito G; Miyakita H; Ogimi T; Nagase H
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1077-1085. PubMed ID: 28417167
[TBL] [Abstract][Full Text] [Related]
9. [A case report of pathologically complete response of rectal cancer after preoperative treatment of CPT-11, S-1, and radiation therapy].
Hamanaka M; Yamano T; Noda M; Tsukamoto K; Kuno T; Yamagishi D; Babaya A; Matsubara N; Kamikonya N; Tomita N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2253-5. PubMed ID: 22202346
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of quality of life by questionnaires between S-1/CPT-11 and mFOLFOX6 in patients with advanced colorectal cancer].
Tokunaga Y; Sasaki H; Matsueda S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1127-31. PubMed ID: 21772096
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
12. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
13. The short-term outcomes of induction SOX (S-1 + oxaliplatin) ± cetuximab chemotherapy followed by short-course chemoradiotherapy in patients with poor-risk locally advanced rectal cancer.
Beppu N; Yoshie H; Kimura F; Aihara T; Doi H; Kamikonya N; Matsubara N; Tomita N; Yanagi H; Yamanaka N
Surg Today; 2016 Oct; 46(10):1123-31. PubMed ID: 26704191
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer.
Jung M; Shin SJ; Koom WS; Jung I; Keum KC; Hur H; Min BS; Baik SH; Kim NK; Kim H; Lim JS; Hong SP; Kim TI; Roh JK; Park YS; Ahn JB
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1015-22. PubMed ID: 26581140
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
[TBL] [Abstract][Full Text] [Related]
16. [Long-term control of sacral metastasis from rectal cancer with S-1 + radiation treatment (RT) and mFOLFOX6 combination therapy--a case report].
Hata T; Fujino S; Yanagawa T; Kitahara T; Munakata K; Watanabe N; Takamoto K; Miyake M; Kawanishi K; Shimizu J; Ikeda K; Fujita J; Iwazawa T; Akagi K; Douno K; Kitada M; Shimano T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2343-5. PubMed ID: 21224567
[TBL] [Abstract][Full Text] [Related]
17. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy with combination of S-1 and CPT-11 in advanced rectal cancer - a case report].
Murakami H; Yamakawa M; Han I; Hatori S; Suzuki M; Iwasaki H; Takanashi Y
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1667-9. PubMed ID: 17940387
[TBL] [Abstract][Full Text] [Related]
19. A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1).
Sato T; Hayakawa K; Tomita N; Noda M; Kamikonya N; Watanabe T; Kato D; Sakai Y; Hiraoka M; Shimada M; Ikushima H; Baba H; Oya N; Oya M; Nemoto-Murofushi K; Takeuchi M; Watanabe M
Radiother Oncol; 2016 Aug; 120(2):222-7. PubMed ID: 27317556
[TBL] [Abstract][Full Text] [Related]
20. [A case of a patient with advanced rectal cancer and urinary bladder fistula surviving for 6 years after chemoradiotherapy without surgery].
Kimura M; Kuroda D; Kawada K; Matsushita H; Nishimura T; Shimokawa Y; Arakawa A; Soh M; Date K
Gan To Kagaku Ryoho; 2014 Aug; 41(8):1017-20. PubMed ID: 25132037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
